120 stasix and 53 resusix delivery for the base period and 120 stasix and 53 resusix for the first option period. Research and development supply for naval medical research unit SAN antonio, texas

Ended Purchase Order Awarded Sep 30, 2015 Last action Sep 8, 2015

Contract number: N6264515P3109
Awardee: Entegrion, Inc. UEI LLK3BJBGY2J5
Awarding agency: Bureau of Medicine and Surgery Department of the Navy, Department of Defense
Obligated: $33,500

Award facts

Opportunity: N6264515RXXXX Solicitation number

To provide the delivery of the platelet-derived hemostatic agent, Stasix, and the spray-dried plasma agent, platelet-derived-Plex, Resusix, in support of the Naval Medical Research Unit San Antonio, Fort Sam Houston, Texas Award Notice · Posted Aug 18, 2015
Contract value 100% obligated: $33,500.41 Current and potential, with all options
Completion date 100% complete: Sep 29, 2017 Current and potential, with all options
NAICS code: 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
PSC: 6515 Medical And Surgical Instruments, Equipment, And Supplies
Set-aside: No set-aside
Competition: Not Competed · 1 offer Only One Source
Pricing: Firm Fixed Price
Place of performance: Grand Island, NY 14072, USA

Award details come from SAM.gov/FPDS.

N6264515P3109 was awarded to Entegrion, Inc. by Bureau of Medicine and Surgery (Department of the Navy) on September 30, 2015.

The government has obligated $33,500 on N6264515P3109.

The extent of competition for N6264515P3109 was not competed. The government received 1 offer.

On GovTribe

Try for free Login